Rhumbline Advisers Amarin Corp Plcuk Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Rhumbline Advisers holds 25,896 shares of AMRN stock, worth $11,912. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,896
Previous 10,086
156.75%
Holding current value
$11,912
Previous $6,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AMRN
# of Institutions
183Shares Held
71.2MCall Options Held
183KPut Options Held
66.7K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$11.4 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$5.71 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$2.03 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.15 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.14 Million0.31% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $185M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...